2018
DOI: 10.1093/infdis/jiy514
|View full text |Cite
|
Sign up to set email alerts
|

Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine

Abstract: Protection against zoster conferred by zoster vaccine live (ZVL; Zostavax™) wanes over time. We compared the cell-mediated immunity (VZV-CMI) of adults ≥70 years who received a second dose of ZVL ≥10 years after the initial dose with de novo-immunized age-matched controls. Before and during the first year after vaccination, VZV-CMI was significantly higher in re-immunized compared with the de novo vaccinees. At 3 years, VZV-CMI differences between groups decreased and only memory responses remained marginally … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 13 publications
0
19
0
Order By: Relevance
“…In addition to this, data on long-term follow-up indicates that vaccine-induced immune responses decline over time. Revaccination can have a booster effect although current evidence is not sufficient to support revaccination of older people (102).…”
Section: Herpes Zoster Vaccinesmentioning
confidence: 87%
“…In addition to this, data on long-term follow-up indicates that vaccine-induced immune responses decline over time. Revaccination can have a booster effect although current evidence is not sufficient to support revaccination of older people (102).…”
Section: Herpes Zoster Vaccinesmentioning
confidence: 87%
“…Therefore, the varicella vaccination coverage should be broadened in China. Moreover, although the varicella vaccine is a live, attenuated vaccine, several studies have indicated that a second dose of the vaccine would provide higher antibody levels [23][24][25]. Moreover, the Advisory Committee on Immunization Practice and German Standing Committee on Vaccination have already recommended a second dose varicella vaccine because of the waning of immunity.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the varicella vaccination coverage should be broadened in China. Although the varicella vaccine is a live, attenuated vaccine, several studies have indicated that a second dose of the vaccine would provide higher antibody levels [23][24][25]. Moreover, the Advisory Committee on Immunization Practice and German Standing Committee on Vaccination have recommended a second dose varicella vaccine because of the waning of immunity.…”
Section: Discussionmentioning
confidence: 99%